Abstract
Effective, accurate, and rapid diagnostic tools for detecting SARS-Covid2 infection are urgently needed to prevent and control the pandemic. While RT-qPCR is a gold standard test for diagnosing SARS-Covid2 infections, this method is limited by the requirement for expensive equipment, experienced staff and specialized molecular laboratory. Recently, the CRISPR cas13 platform was used for the detection of COVID-19. This study evaluated the clinical performance of the CRISPRbased cas13a diagnostic assay for SARS-Covid2. In the current study, the diagnostic performance of the Cas13-based SHERLOCK (Specific High Sensitivity Enzymatic Reporter Unlocking) assay was compared with RT-qPCR in terms of sensitivity, specificity and time consumption. Keywords: Crispr-Cas13; Covid-19; Sherlock
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
